See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

US FDA approves two gene therapies for sickle cell disease

Posted on AllSides December 8th, 2023
From The Center
REUTERS/Erin Scott

The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, making one of them the first treatment in the United States based on the Nobel Prize-winning CRISPR gene editing technology.

Casgevy, developed by partners Vertex Pharmaceuticals (VRTX.O) and CRISPR Therapeutics (CRSP.BN), and bluebird bio's (BLUE.O) Lyfgenia were approved for people aged 12 years and older.

Sickle cell disease (SCD) is a painful, inherited blood disorder in which the body makes flawed, sickle-shaped hemoglobin, impairing the ability of red blood cells to properly carry...

Read full story

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right